Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended:          Nov. 30, 1998
                            ----------------------------------------------------
Commission File Number:     0-11050
                            ----------------------------------------------------

                              Mammatech Corporation
              ----------------------------------------------------
             (Exact name of registrant as specified in its charter)


           Florida                                           59-2181303
 ------------------------------                        --------------------
(State or other jurisdiction of                           (I.R.S. Employer
incorporation or organization)                         Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida                      32601
-----------------------------------------                      -----
(Address of principal executive offices)                     (Zip Code)


                                 (904) 375-0607
               --------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days. Yes       No    X
                                           -----     -----

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                         Number of shares outstanding on

                                                  Nov. 30, 1998
                                           -----------------------------
                                           100,352,500 shares of which
                                           6,208,500 are treasury shares
TITLE OF EACH CLASS
-------------------
Common stock $.0001 par value

The total number of pages of this report is 11.



                                       -1-

<PAGE>

                              Mammatech Corporation

                                      INDEX
--------------------------------------------------------------------------------

PART I.

     FINANCIAL INFORMATION                                    PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended Nov. 30, 1998 and Nov. 30, 1997....................3

         Balance Sheets for Nov. 30, 1998 and
         August 31, 1998........................................4-5

         Statement of Cash Flow for the Quarter
         Ended Nov. 30, 1998......................................6

         Statement of Cash Flow for the Quarter
         Ended Nov. 30, 1998......................................7

         Notes to Financial Statements for the Quarter
         Ended Nov. 30, 1998......................................8


         Item 2.  Management's Discussion and Analysis of
         Financial Conditions and Results of Operations...........9


PART II.     OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K...............10

         SIGNATURES............................................. 11







                                       -2-

<PAGE>

                              Mammatech Corporation
                            Statements of Operations
                                   (Unaudited)

                                                     Three Months Ended
                                             November, 1998       November, 1997
                                             --------------       --------------

Sales, net                                    $     135,632        $     175,012

Cost of sales                                 $      50,564        $      47,925
                                              -------------        -------------

Gross Profit                                  $      85,068        $     127,087
Selling, general and
 administrative expense                       $     109,924        $      79,906
                                              -------------        -------------

Operating Income (Loss)                       $     (24,856)       $      47,181

Other income
(expense)
Reimbursement (SBIR Grant)                           57,002               26,307
 Interest & Dividend Income                           6,811                3,830
                                              -------------        -------------
                                                     63,813               30,136

Net Income before taxes                       $      38,957               77,317
Provision for income taxes                                0                    0
Net Income                                           38,957               77,317




NET INCOME (LOSS)                                    38,957               77,317
                                              =============        =============

Net income (loss) per share                           .0004                .0008
                                              =============        =============

Weighted average shares                         100,352,500          100,352,500
                                              =============        =============







    The accompanying notes are an integral part of the financial statements.


                                       -3-

<PAGE>

                              Mammatech Corporation

                                 Balance Sheets

                                                       Nov. 30,         Aug. 31,
                                                         1998            1998
                                                     (Unaudited)       (Audited)
                                                     -----------       ---------
ASSETS
------

  Cash and Cash Equivalents                            $406,677         $342,740
  Available for sale:
         securities                                     106,445           94,377
  Accounts receivable:
    Trade                                                47,833           74,983
    Other                                                 3,190            3,190

  Inventory                                             198,714          201,574
  Other current assets

  Total Current Assets                                  762,859          716,864
  --------------------                                 --------         --------

Property and equipment                                   44,180           43,622

Other assets:

    Other investments

Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $66,955 and $64,675
    respectively                                          7,392            8,657
                                                       --------         --------

    Total other assets                                    7,392            8,657
    ------------------                                 --------         --------

TOTAL ASSETS                                           $814,431         $769,143
                                                       ========         ========




    The accompanying notes are an integral part of the financial statements.


                                       -4-

<PAGE>

                              Mammatech Corporation
                                 Balance Sheets
                              As of August 31, 1998
                                and Nov. 30, 1998
                                   (continued)

                                                    Nov.1998         Aug. 1998
                                                    --------         ---------

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES
-------------------

Current portion of long term debt                 $     4,796       $     4,796
Accounts payable-trade                                 44,314            48,595
Customer deposits                                         -0-               -0-
Accrued payable-officer                                 6,630             6,630
Accrued expenses                                      164,120           163,966
                                                  -----------       -----------


TOTAL CURRENT LIABILITIES                             219,860           223,987
                                                  -----------       -----------

COMMITMENTS
  Long term debt                                        1,940             1,940

Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  100,352,500 shares issued
  and outstanding                                 $    10,035       $    10,035

  Additional paid-in capital                        2,809,594         2,809,594
  Accumulated deficit                              (2,091,016        (2,109,926
                                                  -----------       -----------
                                                      728,613           709,703

  Valuation allowance: mkt. sec                        12,068           (18,436)
  Treasury stock at cost,
  6,208,500 shares                                   (148,051)         (148,051)
                                                  -----------       -----------
                                                      592,631           543,216
                                                  -----------       -----------

TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY                              $   814,431       $   769,143
                                                  ===========       ===========


        The accompanying notes are an integral part of these statements.



                                       -5-

<PAGE>

                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Three Months Ending
                                  Nov. 30, 1998




Net cash flow from operating activities                                 $ 63,379
                                                                        ========

Investing Activities:

Purchase of fixed assets                                                     558
Financing activities:
    Issuance of treasury shares                                              -0-

Net increase (decrease) in cash                                           63,937

         Beginning cash                                                  342,740
                                                                        --------

Ending cash                                                             $406,677
                                                                        ========






    The accompanying notes are an integral part of the financial statements.


                                       -6-

<PAGE>
                              Mammatech Corporation
                          Notes to Financial Statements
                                  Nov. 30, 1998



Note 1.   In the opinion of the Company,  the accompanying  unaudited  financial
          statements   contain  all  adjustments   (consisting  of  only  normal
          recurring accruals) necessary to present fairly the financial position
          as of Nov.  30,  1998,  and the results of  operations  and changes in
          financial position for the three months ended Nov. 30, 1998.


Note 2.   Loss per  share is based on the  weighted  average  number  of  shares
          outstanding during each period.

Note 3.   Gives effect to the Company's  repurchasing  7,558,500 shares of stock
          from shareholders for treasury stock.






                                       -7

<PAGE>


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF
OPERATION FOR MAMMATECH CORPORATION


For the first quarter of Fiscal 1999,net sales decreased 23.2% from the previous
quarter  and were  22.5%  below the first  quarter of 1997.  Operating  costs of
$109,924  decreased of 42% relative to the previous  quarter but increased 37.6%
in comparison to the same period last year.Part of the decrease  compared to the
fourth  quarter of 1998 is the result of accruals  charged to that period during
the  audit.  The net income for the  quarter  was 49.6%  below that of the first
quarter of 1998 but, because of the accruals, cannot be meaningfully compared to
the net income of the previous quarter.

The  most  significant  development  of the  quarter  was the  expansion  of the
Company's  professional training program. Two highly qualified nurses were hired
to replace the previous Director who resigned to pursue other interests.  During
the quarter,  16 new MammaCare  Specialists  were trained  compared to seven the
previous quarter.  Additionally,  a focused marketing program is being developed
to enhance this aspect of the Company's business.  Part of this program involves
publicizing the  achievements of each new MammaCare  Specialist on the Company's
expanded web site.

The  Company is  presently  in the second  year of its Phase II SBIR grant under
which  MammaCare  products are being  developed for women with vision or hearing
impairments.  Further,in  response the repeated demand from existing  customers,
selected MammaCare products are now available in Spanish.  Of course,  there can
be no assurance  that  significant  revenues will result from the sale of any of
these products.

With  the  exception  of  a  small  note  to  an  unaffiliated  supplier  for  a
manufacturing  facility,  the  Company  remains  debt free and has no  immediate
liquidity  problems.  It continues to seek a  relationship  with a larger health
care organization.

YEAR 2000 IMPLICATIONS.  Many currently  installed computer systems and software
products are coded to accept only  two-digit  entries in the date code field and
cannot reliably  distinguish dates beginning on January 1, 2000 from dates prior
to the year 2000. Many companies'  software and computer  systems may need to be
upgraded or replaced in order to process  correctly  dates beginning in 2000 and
to comply  with the "Year 2000"  requirements.  The  Company  has  reviewed  its
systems and internal  programs and has determined  that there are no significant
Year 2000  problems exist. None  of the  Company's  products are in any way date
sensitive. However, although the Company believes that its systems are Year 2000
compliant,  the equipment and software of its suppliers and  subcontractors  may
not be Year 2000 compliant. Failure of such third-party equipment or software to
properly  process  dates  for the year 2000 and  thereafter  could  require  the
Company to incur unanticipated expenses to remedy any problems, which could have
a materially adverse effect on its business, results of operations and financial
condition.


                                       -8-

<PAGE>

PART II - OTHER INFORMATION
---------------------------




Item 6.    Exhibits and Reports on Form 8-K

   (a.)    Exhibits - None

   (b.)    There were no reports filed on Form 8-K during the three
           months ending Nov. 30, 1998.





                                       -9-

<PAGE>
                                      10-Q

                    For the three months ended Nov. 30, 1998

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                         MAMMATECH CORPORATION
                                         ---------------------

DATE: January 14, 1999                   BY: /s/  Henry S. Pennypacker
                                             -----------------------------------
                                              Henry S. Pennypacker, President
                                              and Director

                                         BY: /s/  Mary Sellers
                                             -----------------------------------
                                             Mary Sellers, Treasurer and
                                             Chief Financial Officer





                                      -10-